Etiqueta: stem cells

Scientists report a new and highly efficient, improved procedure for the reprogramming of adult human somatic cells into iPS (induced pluripotent stem) cells.

The politics of stem cells are reviewed within the context of the current U.S. presidential election.

Now that it is possible to create pluripotent stem cells without the need for embryos, stem cell research labs are springing up by the hundreds – despite the fact that one critical problem still remains.

European researchers have coaxed testicular sperm-producing cells into new cells that behave like embryonic stem cells.

At the start of a major conference, the man who first introduced embryonic stem cells to the world delivers a cautionary message.

The combined results of two independent groups of researchers represent major progress in the development of safer, more efficiently produced iPS (induced pluripotent stem) cells.

Plans are underway at The Anthony Nolan Trust Cord Blood Bank at Nottingham Trent University in England for a major processing and storage facility of cord blood.

Michael West, CEO of BioTime, Inc., schedules key stem cell licensing topics for conference call.